Clinical Trial
Oral retinoid for psoriasis. A report of a double blind study
- PMID: 393035
Item in Clipboard
Clinical Trial
Oral retinoid for psoriasis. A report of a double blind study
Acta Derm Venereol Suppl (Stockh).
1979.
Abstract
Oral administration of an aromatic retinoid has a marked beneficial effect on psoriasis and does not produce significant changes in liver function or the blood count when given at a dose of 25 mgm three times a day for six weeks. This effect does not occur unless the drug has produced dermatological side-effects and this may inhibit its future acceptance but the present findings indicate that, at least in the less developed parts of the world where many Western treatments are unacceptable for various reasons, oral retinoids are a useful and relatively safe addition to the present range of medications available for psoriasis.
Similar articles
-
[Treatment of plaque psoriasis with an aromatic retinoid (etretinate)].Rev Med Chil. 1984 Jan;112(1):20-5. Rev Med Chil. 1984. PMID: 6377426 Clinical Trial. Spanish. No abstract available.
-
A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.Acta Derm Venereol. 1989;69(1):35-40. Acta Derm Venereol. 1989. PMID: 2563606 Clinical Trial.
-
Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.Dermatologica. 1982 Sep;165(3):204-7. Dermatologica. 1982. PMID: 6751889 Clinical Trial. No abstract available.
-
International studies of the efficacy of etretinate in the treatment of psoriasis.J Am Acad Dermatol. 1982 Apr;6(4 Pt 2 Suppl):692-6. doi: 10.1016/s0190-9622(82)70058-1. J Am Acad Dermatol. 1982. PMID: 7040512 Review.
-
[Treatment of psoriasis using vitamin A, vitamin A acid and oral retinoids].Hautarzt. 1979 Mar;30(3):124-33. Hautarzt. 1979. PMID: 374312 Review. German.
Cited by
-
Clinical pharmacokinetics of the retinoids.Clin Pharmacokinet. 1985 Jan-Feb;10(1):38-62. doi: 10.2165/00003088-198510010-00002. Clin Pharmacokinet. 1985. PMID: 3882304 Review.
-
Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.Drugs. 1983 Jul;26(1):9-43. doi: 10.2165/00003495-198326010-00002. Drugs. 1983. PMID: 6224672 Review.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
The retinoids. A review of their clinical pharmacology and therapeutic use.Drugs. 1987 Oct;34(4):459-503. doi: 10.2165/00003495-198734040-00003. Drugs. 1987. PMID: 3315625 Review.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2023 Jul 12;7(7):CD011535. doi: 10.1002/14651858.CD011535.pub6. Cochrane Database Syst Rev. 2023. PMID: 37436070 Free PMC article. Review.